1201 - 1210 of 6403 Results
Title
Year
-
OPENTitle: Effects of Nabilone on Sleep Outcomes in Patients with Parkinson's Disease: A Post‐hoc Analysis of NMS‐Nab StudyJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 9Issue #: 6Start Page: 751End Page: 758Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mdc3.13471Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13471Citation Count: 18
-
OPENTitle: Disrupted Brain Structural Network Connection in de novo Parkinson's Disease With Rapid Eye Movement Sleep Behavior DisorderJournal Name: Frontiers in Human NeurosciencePublisher: Frontiers Media SAVol: 16Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnhum.2022.902614Best OA location URL: https://doi.org/10.3389/fnhum.2022.902614Citation Count: 4
-
OPENTitle: Clinical trajectories and biomarkers for weight variability in early Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-022-00362-3Best OA location URL: https://www.nature.com/articles/s41531-022-00362-3.pdfCitation Count: 15
-
OPENTitle: Therapeutic deep brain stimulation disrupts movement-related subthalamic nucleus activity in parkinsonian miceJournal Name: eLifePublisher: eLife Sciences Publications, LtdVol: 11Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.7554/elife.75253Best OA location URL: https://doi.org/10.7554/elife.75253Citation Count: 40
-
OPENTitle: Patient Experience in Early-Stage Parkinson’s Disease: Using a Mixed Methods Analysis to Identify Which Concepts Are Cardinal for Clinical Trial Outcome AssessmentJournal Name: Neurology and TherapyPublisher: Springer Science and Business Media LLCVol: 11Issue #: 3Start Page: 1319End Page: 1340Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1007/s40120-022-00375-3Best OA location URL: https://link.springer.com/content/pdf/10.1007/s40120-022-00375-3.pdfCitation Count: 26
-
OPENTitle: Screening, Diagnosis, and Management of Parkinson’s Disease Psychosis: Recommendations From an Expert PanelJournal Name: Neurology and TherapyPublisher: Springer Science and Business Media LLCVol: 11Issue #: 4Start Page: 1571End Page: 1582Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1007/s40120-022-00388-yBest OA location URL: https://link.springer.com/content/pdf/10.1007/s40120-022-00388-y.pdfCitation Count: 9
-
OPENTitle: GBA and APOE Impact Cognitive Decline in Parkinson's Disease: A 10‐Year Population‐Based StudyJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 5Start Page: 1016End Page: 1027Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1002/mds.28932Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28932Citation Count: 90
-
OPENTitle: Targeted copy number variant identification across the neurodegenerative disease spectrumJournal Name: Molecular Genetics & Genomic MedicinePublisher: WileyVol: 10Issue #: 8Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mgg3.1986Best OA location URL: https://doi.org/10.1002/mgg3.1986Citation Count: 4
-
OPENTitle: Sex differences in the genetic architecture of cognitive resilience to Alzheimer’s diseaseJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 145Issue #: 7Start Page: 2541End Page: 2554Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1093/brain/awac177Best OA location URL: https://academic.oup.com/brain/article-pdf/145/7/2541/45191149/awac177.pdfCitation Count: 65
-
OPENTitle: Opicapone as an Add-on to Levodopa in Patients with Parkinson’s Disease Without Motor Fluctuations: Rationale and Design of the Phase III, Double-Blind, Randomised, Placebo-Controlled EPSILON TrialJournal Name: Neurology and TherapyPublisher: Springer Science and Business Media LLCVol: 11Issue #: 3Start Page: 1409End Page: 1425Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1007/s40120-022-00371-7Best OA location URL: https://link.springer.com/content/pdf/10.1007/s40120-022-00371-7.pdfCitation Count: 7